|
已读[48]
发布： 2013/06/18 21:14:59
PR Newswire (press release) MADRID, June 13, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the results from the CONCERTO trial, the first randomized, controlled trial assessing different predefined doses of methotrexate (MTX) in combination with HUMIRA® ...
|
|
|
|
|
已读[115]
发布： 2013/06/18 17:49:39
这类止疼药在医学上被称为非甾体类抗炎药,常用的有布洛芬、双氯芬酸等,它们能治“标”,即缓解关节痛和肿,但不能治“本”,即组织关节破坏和变形;长期乱用可能出现胃痛、消化不良、胃溃疡等问题,还可能伤害肝肾,给后续治疗带来困难。 用激素不当伤骨头。...
|
|
|
|
|
已读[329]
发布： 2013/06/18 17:36:05
患者5年前无明显诱因出现右颌下腺肿大,无疼痛,间断自服抗炎药物无好转,且肿大逐渐加重,遂于辽宁省某医院行右颌下腺切除术,...实验室检查:血常规:白细胞4.77×109/L,中性粒细胞0.518,血红蛋白126g/L,血小板115×109/L;尿常规:尿蛋白(-),白细胞6.87个/高倍视野,红细胞5.2个/高倍视野;抗链球菌溶血素O 27 U/ml,...
|
|
|
|
|
已读[44]
发布： 2013/06/16 10:38:22
MarketWatch MADRID, June 13, 2013 /PRNewswire via COMTEX/ -- AbbVie (NYSE:ABBV) today announced the results from the CONCERTO trial, the first randomized, controlled trial assessing different predefined doses of methotrexate (MTX) in combination with ...
|
|
|
|
|
已读[42]
发布： 2013/06/16 10:37:53
Business Wire (press release) EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced subcutaneous methotrexate delivered with a new, self-administration device demonstrates bioavailability that is significantly greater than oral methotrexate in the ... and more »
|
|
|
|
|
已读[91]
发布： 2013/06/15 13:10:39
【药理作用】甲氨蝶呤对二氢叶酸还原酶有强大而持久的抑制作用,使5,10-甲撑四氢叶酸不足,脱氧胸苷酸(dTMP)合成受阻,影响DNA合成(图49-4);MTX也可阻止嘌呤...
|
|
|
|
|
已读[50]
发布： 2013/06/15 13:10:04
4、免疫因素,牛皮癣的表皮角朊细胞增生和炎症细胞聚集可能与免疫系统的细胞或非细胞成分都有关系;而且与免疫有关的药物如甲氨蝶呤,皮质类固醇激素,环孢素等常用...
|
|
|
|
|
已读[44]
发布： 2013/06/15 13:08:52
dailyRx (dailyRx News) Methotrexate is often the first choice of medication to treat rheumatoid arthritis (RA). When methotrexate alone doesn't do the trick, patient...
|
|
|
|
|
已读[44]
发布： 2013/06/15 13:08:11
EON: Enhanced Online News (press release) PARIS--(EON: Enhanced Online News)--Bristol-Myers Squibb Company (NYSE: BMY) has today announced that on 1 July 2010 the European Commission approved a new indication for ORENCIA® (abatacept), in combination with methotrexate (MTX), ...
|
|
|
|
|
已读[45]
发布： 2013/06/15 13:07:53
MarketWatch MADRID, June 13, 2013 /PRNewswire via COMTEX/ -- AbbVie (NYSE:ABBV) today announced the results from the CONCERTO trial, the first randomized, controlled trial assessing different predefined doses of methotrexate (MTX) in combination with ...
|
|
|
« 上一页 |
查看结果91-100共335
|
下一页 »
|
|
